✦ LIBER ✦

170 Anti-AML chemotherapy in high-risk MDS: The M.D. Anderson cancer center experience

✍ Scribed by E. Estey

Book ID: 114119347
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 152 KB
Volume: 21
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(97)81368-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary Chemotherapy in the Treatment of

Primary Chemotherapy in the Treatment of Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience

✍ Vicente Valero; Aman U. Buzdar; Marsha McNeese; Eva Singletary; Gabriel N. Horto 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 131 KB

Laryngeal preservation by induction chem

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M. D. Anderson cancer center experience

✍ Dr. Mihran H. Shirinian; Dr. Randal S. Weber; Dr. Scott M. Lippman; Dr. Isaiah W 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Standard treatment of locally advanced laryngeal, hypopharyngeal, and some oropharyngeal cancers includes total laryngectomy. In an attempt to preserve the larynx through induction chemotherapy, we conducted two consecutive phase ll studies. From March 1986 to February 1991, 64 patients with advance

Phase I/II trial of high dose mitoxantro

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

✍ Massimo Cristofanilli; Frankie Ann Holmes; Laura Esparza; Vicente Valero; Aman U 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 68 KB